Core Tip: KRAS mutation is currently listed as an additional prognostic factor in AJCC-UICC staging guidelines [6], NICE [47], Australian Cancer Care [9], and ESMO [46] guidelines on colorectal cancer. Here, KRAS is linked to cancer.